HLA mismatch direction in cord blood transplantation: Impact on outcome and implications for cord blood unit selection

Blood

Volumn 118, Issue 14, 2011, Pages 3969-3978

  Stevens, Cladd E ^a   Carrier, Carmelita ^a   Carpenter, Carol ^a   Sung, Dorothy ^a   Scaradavou, Andromachi ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ARTICLE; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

EID: 80053639148     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-11-317271     Document Type: Article

References (41)

1. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord blood transplantation from related and unrelated donors: Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med. 1997;337(6):373-381.
2. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339(22):1565-1577. (Pubitemid 28536131)
3. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. N Engl J Med. 2001;344(24):1815-1822. (Pubitemid 32538694)
4. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351(22):2265-2275. (Pubitemid 39552742)
5. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351(22):2276-2285. (Pubitemid 39552743)
6. Eapen M, Rubinstein P, Zhang M-J, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study. Lancet. 2007;369(9577):1947-1954. (Pubitemid 46874578)
7. Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood. 1996;88(3):795-802. (Pubitemid 26333297)
8. Rocha V, Wagner JE Jr, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med. 2000;342(25):1846-1854. (Pubitemid 30419048)
9. MacMillan ML, Weisdorf DJ, Brunstein CG, et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood. 2009;113(11):2410-2415.
10. World Marrow Donor Association. 2009 Annual Report. Leiden, The Netherlands; World Marrow Donor Association: 2010.
11. Mold JE, Michaëlsson J, Burt TD, et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science. 2008;322(5907):1562-1565.
12. Burlingham WJ. A lesson in tolerance: maternal instruction to fetal cells. N Engl J Med. 2009;360(13):1355-1357.
13. Van Rood JJ, Stevens CE, Schmits J, Carrier C, Carpenter C, Scaradavou A. Re-exposure of cord blood to non-inherited maternal HLA antigens improves transplant outcome in hematological malignancies. Proc Nat Acad Sci U S A. 2009;106(47):19952-19957.
14. Weiden PL, Flournoy N, Thomas ED, et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. N Engl J Med. 1979;300(19):1068-1073. (Pubitemid 9198740)
15. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990;75(3):555-562. (Pubitemid 20069191)
16. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A. 1995;92(22):10119-10122.
17. Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE. Stored placental blood for unrelated bone marrow reconstitution. Blood. 1993;81(7):1679-1690. (Pubitemid 23101579)
18. Szydlo R, Goldman JM, Klein JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol. 1997;15(5):1767-1777. (Pubitemid 27209503)
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457-481.
20. Klein JP, Moeschberger ML. Survival Analysis: Techniques of Censored and Truncated Data. New York, NY: Springer-Verlag; 2003.
21. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496-509.
22. Cox DR. Regression models and life tables. J R Stat Soc. 1972;34(2):187-220.
23. Barker JN, Scaradavou A, Stevens CE. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematological malignancies. Blood. 2010;115(9):1843-1849.
24. Spellman S, Warden MB, Haagenson M, et al. Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. Biol Blood Marrow Transplantation. 2009;15(7):856-863.
25. Van Halteren AGS, Jankowska-Gan E, Joosten A, et al. Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy families. Blood. 2009;114(11):2263-2272.
26. Kögler G, Enczmann J, Rocha V, Gluckman E, Wernet P. High-resolution HLA typing by sequencing for HLA-A, -B, -C, -DR, -DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplant. 2005;36(12):1033-1041. (Pubitemid 43078130)
27. Matsuno N, Wake A, Uchida N, et al. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. Blood. 2009;114(8):1689-1695.
28. Ottinger HD, Ferencik S, Beelen DW, et al. Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA matched unrelated donors. Blood. 2003;102(3):1131-1137. (Pubitemid 36917816)
29. Eapen M, Rocha V, Sanz G, et al. Effect of graft source on unrelated donor haemopeoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol. 2010;11(9):653-660.
30. Kamei H, Oike F, Fujimoto Y, Yamamoto H, Tanaka K, Kiuchi T. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching. Liver Transplant. 2006;12(1):140-145.
31. Grosskreutz C, Gudzowaty O, Shi P, Rodriguez-Laiz G, Malone A, Isola L. Partial HLA matching and RH compatibility resulting in graft versus host reaction and Evans syndrome after liver transplantation. Am J Hematol. 2008;83(7):599-601. (Pubitemid 351874882)
32. Weinstein A, Dexter D, Kuruga DL, Philosophe B, Hess J, Klassen D. Acute graft-versus-host disease in pancreas transplantation: a comparison of two case presentations and review of the literature. Transplantation. 2006;82(1):127-131. (Pubitemid 44296988)
33. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110(13):4576-4583. (Pubitemid 351377826)
34. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 2004;104(7):1923-1930. (Pubitemid 39297840)
35. Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of two partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005;105(3):1343-1347. (Pubitemid 40170912)
36. Mackinnon S, Papadopoulos EB, Carabasi MH, et al. Adoptive immunotherapy evaluating the escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood. 1995;86(4):1261-1268.
37. Yahata T, Ando K, Miyatake H, et al. Competitive repopulation assay of two gene-marked cord blood units in NOC/SCIDgammacnull mice. Mol Ther. 2004;10(5):882-891. (Pubitemid 39419915)
38. Hexner EO, Danet-Dosnoyers GH, Zhang Y, et al. Umbilical cord blood xenografts in immunodeficient mice reveal the T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation. Biol Blood Marrow Transplant. 2007;13(10):1135-1144. (Pubitemid 47413014)
39. Gutman JA, Turtle CJ, Manley TJ, et al. Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit. Blood. 2010;115(4):757-765.
40. Eldjerou LK, Chaudhury S, Baisre-de Leon, et al. An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment. Blood. 2010;116(19):3999-4006.
41. Stevens CE, Rubinstein P, Scaradavou A. HLA matching in cord blood transplantation: clinical outcome and implications for cord blood unit selection and inventory size and ethnic composition [abstract]. Blood. 2007;110(11): Abstract 3104.